Skip to main content
Login
Contact
Subscribe
Search form
Search
The Sweetwater Reporter
Home
Forms
News
Sports
Classifieds
Obituaries
Entertainment
Local Guide
Special Sections
Talking About...
Photos
Videos
Games
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
NYSE COMPOSITE INDX
Gold
Crude Oil
ADVERUM BIOTECHN RG
(NQ:
ADVM
)
5.050
USD
-0.100 (-1.94%)
Official Closing Price
/ Updated:
8:00 PM EDT, Jul 20, 2018
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
423,825
Open
5.150
Bid (Size)
4.600 (200)
Ask (Size)
5.250 (800)
Prev. Close
5.150
Today's Range
4.900 - 5.250
52wk Range
2.400 - 8.590
Shares Outstanding
62,271,901
Dividend Yield
N/A
Performance
YTD
+38.36%
+38.36%
1 Month
-15.83%
-15.83%
3 Month
-19.84%
-19.84%
6 Month
+3.06%
+3.06%
1 Year
+90.57%
+90.57%
Top News
More News
Adverum Biotechnologies to Present at the 2018 Jefferies Global Healthcare Conference
June 04, 2018
Adverum Biotechnologies, Inc. (Nasdaq:ADVM), a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases, announced today that Leone Patterson, interim...
Read More
from
GlobeNewswire News Releases
Analysis: Positioning to Benefit within Kinross Gold, New York Mortgage Trust, POSCO, NXP Semiconductors N.V, Baidu, and Adverum Biotechnologies — Research Highlights Growth, Revenue, and Consolidated
June 04, 2018
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Kinross Gold Corporation...
Read More
from
GlobeNewswire News Releases
More News
Read More
Markets soar as inflation fears ease
May 04, 2018
category
Market News
from
MarketMinute.com Market Updates
Adverum Biotechnologies Presents Additional Long-term Preclinical Data on ADVM-022 in Wet AMD at ASGCT 21st Annual Meeting
May 17, 2018
from
GlobeNewswire News Releases
Adverum Biotechnologies Reports First Quarter 2018 Financial Results and Provides Corporate Update
May 09, 2018
from
GlobeNewswire News Releases
Adverum Biotechnologies Announces Leadership Changes
May 03, 2018
from
GlobeNewswire News Releases
Adverum Biotechnologies Announces Long-term Preclinical Efficacy Data on ADVM-022 Gene Therapy in Wet AMD
May 01, 2018
from
GlobeNewswire News Releases
Research Report Identifies Teck Resources, Adverum Biotechnologies, BeiGene, IPG Photonics, Arsanis, and G1 THERAPEUTICS with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement
April 09, 2018
from
GlobeNewswire News Releases
Interesting ADVM Put And Call Options For August 17th
June 21, 2018
category
Stocks
from
Market News Video
First Week of ADVM July 20th Options Trading
May 22, 2018
category
Stocks
from
Market News Video
PZI's Underlying Holdings Could Mean 11% Gain Potential
April 25, 2018
category
ETFs
from
ETF Channel
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
